Additional evidence against widespread use of inpatient antiplatelet therapy in coronavirus infection: data from a randomized controlled trial

Ítems similars

• RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE
  per: D. H. Aynetdinova, et al.
  Publicat: (2015-12-01)
• Review of the Ticagrelor Trials Evidence Base
  per: Grace C. Herron, et al.
  Publicat: (2024-06-01)
• Dual Antiplatelet Therapy in Coronary Artery Disease
  per: Raghav Sharma, et al.
  Publicat: (2020-08-01)
• PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW
  per: I. S. Yavelov
  Publicat: (2017-09-01)
• Effect of ticagrelor versus clopidogrel after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome—propensity score matching analysis
  per: Yinan Zhao, et al.
  Publicat: (2024-01-01)